Abstract
Purpose
The aim of this article is to provide an overview of clinical and translational research on intradiscal platelet-rich plasma (PRP) as a minimally invasive treatment for discogenic low back pain.
Methods
A literature review of in vitro, in vivo, and clinical studies was performed.
Results
There is strong in vitro evidence that supports the use of intradiscal PRP for discogenic low back pain. There are also promising findings in select preclinical animal studies. A clinical study of 29 participants who underwent intradiscal PRP injections for discogenic low back pain found statistically and clinically significant improvements in pain and function through two years of follow-up.
Conclusions
Intradiscal PRP is a safe and a possibly effective treatment for discogenic low back pain. Future studies are warranted to determine the best candidates for this treatment, what the optimal injectate is and what relationships exist between patient-reported outcomes and radiological findings.
Similar content being viewed by others
References
Frank JW, Brooker AS, DeMaio SE et al (1996) Disability resulting from occupational low 353 back pain. part I: What do we know about primary prevention? A review of the scientific 354 evidence on prevention before disability begins. Spine (Phila Pa 1976) 21(24):2908–2917
Andersson GB (1999) Epidemiological features of chronic low-back pain. Lancet 354(9178):581–585
Frymoyer JW, Cats-Baril WL (1991) An overview of the incidences and costs of low back pain. Orthop Clin North Am 22(2):263–271
Schwarzer AC, Aprill CN, Derby R, Fortin J, Kine G, Bogduk N (1995) The prevalence and clinical features of internal disc disruption in patients with chronic low back pain. Spine 20(17):1878–1883
Roberts S (2006) Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am 88(Suppl_2):10
Migacz K, Chłopek J, Morawska-Chocho’ł A, Ambroziak M (2014) Gradient composite materials for artificial intervertebral discs. Acta Bioeng Biomech 16(3):3–12
Bogduk N (2005) Clinical anatomy of the lumbar spine and sacrum, 4th edn. Elsevier, USA, pp 147–148
Weiler C, Nerlich AG, Bachmeier BE et al (2005) Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine 30:44–53
Le Maitre CL, Freemont AJ, Hoyland JA (2005) The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 7:R732–R745
Hoyland JA, Le Maitre CL, Freemont AJ (2008) Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology 47:809–814
Di Martino A, Vaccaro AR, Yung Lee J, Denaro V, Lim MR (2005) Nucleus pulposus replacement: basic science and indications for clinical use. Spine 30(16 Suppl):S16–S22
Di Martino A, Merlini L, Faldini C (2013) Autoimmunity in intervertebral disc herniation: from bench to bedside. Expert Opin Ther Targets 17(12):1461–1470
Karasek M, Bogduk N (2000) Twelve-month follow- up of a controlled trial of intradiscal thermal annuloplasty for back pain due to internal disc disruption. Spine 25:2601–2607
Bogduk N, Karasek M (2002) Two-year follow-up of a controlled trial of intradiscal electrothermal anuloplasty for chronic low back pain resulting from internal disc disruption. Spine J 2:343–350
Gerszten PC, Welch WC, McGrath PM, Willis SL (2002) A prospective outcome study of patients undergoing intradiscal electrothermy (IDET) for chronic low back pain. Pain Physician 5:360–364
Lee MS, Cooper G, Lutz GE, Doty S (2003) Intradiscal electrothermal therapy (IDET) for treatment of chronic lumbar discogenic pain: a minimum 2-year clinical outcome study. Pain Physician 6:443–448
Freedman BA, Cohen SP, Kuklo TR, Lehman RA, Larkin P, Giuliani JR (2003) Intradiscal electrothermal therapy (IDET) for chronic low back pain in active-duty soldiers: 2- year follow-up. Spine J 3:502–509
Boswell MV, Trescot AM, Datta S, Schultz DM, Hansen HC, Abdi S, Sehgal N, Shah RV, Singh V, Benyamin RM, Patel VB, Buenaventura RM, Colson JD, Cordner HJ, Epter RS, Jasper JF, Dunbar EE, Atluri SL, Bowman RC, Deer TR, Swicegood JR, Staats PS, Smith HS, Burton AW, Kloth DS, Giordano J, Manchikanti L (2007) American Society of Interventional Pain Physicians. Interventional techniques: evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician 10(1):7–111
Cook CE, Arnold PM, Passias PG et al (2015) Predictors of pain and disability outcomes in one thousand, one hundred and eight patients who underwent lumbar discectomy surgery. Int Orthop 39(11):2143–2151
Cheng J, Wang H, Zheng W et al (2013) Reoperation after lumbar disc surgery in two hundred and seven patients. Int Orthop 37(8):1511–1517
Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835–870
Wang SZ, Chang Q, Lu J, Wang C (2015) Growth factors and platelet-rich plasma: promising biological strategies for early intervertebral disc degeneration. Int Orthop 39(5):927–934. doi:10.1007/s00264-014-2664-8
Anitua E, Andia I, Arddnza B, Nurden P, Nurden AT (2004) Autologous platelets as a source for healing and tissue regeneration. Thromb Haemost 91:4–15
Bennett NT, Schultz GS (1993) Growth factors and wound healing: part II. Role in normal and chronic wound healing. Am J Surg 166(1):74–81
Kajikawa Y, Morihara T, Sakamoto H, Matsuda K, Oshima Y, Yoshida A et al (2008) Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing. J Cell Physiol 215(3):837–845
Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, Harrison JR, Gribbin CK, LaSalle EE, Nguyen JT, Solomon JL, Lutz GE (2015) Lumbar intradiscal platelet rich plasma (PRP) injections: a prospective, double-blind, randomized controlled study. PM R. doi:10.1016/j.pmrj.2015.08.010
Chen WH, Lo WC, Lee JJ, Su CH, Lin CT, Liu HY, Lin TW, Lin WC, Huang TY, Deng WP (2006) Tissue-engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF-beta1 in platelet-rich plasma. J Cell Physiol 3:744–754
Akeda K, An HS, Pichika R, Attawia M, Thonar EJ, Lenz ME, Uchida A, Masuda K (2006) Platelet-rich plasma (PRP) stimulates the extracellular matrix metabolism of porcine nucleus pulposus and anulus fibrosus cells cultured in alginate beads. Spine (Phila Pa 1976) 31(9):959–966
Kim HJ, Yeom JS, Koh YG, Yeo JE, Kang KT, Kang YM, Chang BS, Lee CK (2014) Anti-inflammatory effect of platelet-rich plasma on nucleus pulposus cells with response of TNF-a and IL- 1J. Orthop Res 32(4):551–556
Liu MC, Chen WH, Wu LC, Hsu WC, Lo WC, Yeh SD, Wang MF, Zeng R, Deng WP (2014) Establishment of a promising human nucleus pulposus cell line for intervertebral disc tissue engineering. Tissue Eng Part C Methods 20(1):1–10
Pirvu TN, Schroeder JE, Peroglio M, Verrier S, Kaplan L, Richards RG, Alini M, Grad S (2014) Platelet-rich plasma induces annulus fibrosus cell proliferation and matrix production. Eur Spine J 23(4):745–753
Nagae M, Ikeda T, Mikami Y et al (2007) Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres. Tissue Eng 13:147–158
Sawamura K, Ikeda T, Nagae M et al (2009) Characterization of in vivo effects of platelet-rich plasma and biodegradable gelatin hydrogel microspheres on degenerated intervertebral discs. Tissue Eng Part A 15:3719–3727
Gullung GB, Woodall JW, Tucci MA et al (2011) Platelet-rich plasma effects on degenerative disc disease: analysis of histology and imaging in an animal model. Evid Based Spine Care J 2:13–18
Hou Y, Shi G, Shi J, Xu G, Guo Y, Xu P (2015) Study design: in vitro and in vivo assessment of bone morphogenic protein 2 combined with platelet-rich plasma on treatment of disc degeneration. Int Orthop. 2015. PMID: 26169838
Obata S, Akeda K, Imanishi T, Masuda K, Bae W, Morimoto R, Asanuma Y, Kasai Y, Uchida A, Sudo A (2012) Effect of autologous platelet-rich plasma-releasate on intervertebral disc degeneration in the rabbit anular puncture model: a preclinical study. Arthritis Res Ther 14(6):R241
Chen WH, Liu HY, Lo WC, Wu SC, Chi CH, Chang HY, Hsiao SH, Wu CH, Chiu WT, Chen BJ, Deng WP (2009) Intervertebral disc regeneration in an ex vivo culture system using mesenchymal stem cells and platelet-richplasma. Biomaterials 30:5523–5533
Furmaniak-Kazmierczak E, Cooke TD, Manuel R, Scudamore A, Hoogendorn H, Giles AR, Nesheim M (1994) Studies of thrombin-induced proteoglycan release in the degradation of human and bovine cartilage. J Clin Invest 94:472–480
Gui K, Ren W, Yu Y, Li X, Dong J, Yin W (2015) Inhibitory effects of platelet-rich plasma on intervertebral disc degeneration: a preclinical study in a rabbit model. Med Sci Monit 21:1368–1375
Illien-jünger S, Lu Y, Purmessur D et al (2014) Detrimental effects of discectomy on intervertebral disc biology can be decelerated by growth factor treatment during surgery: a large animal organ culture model. Spine J 14(11):2724–2732
Acknowledgments
The platelet-rich plasma preparation kits used in the clinical study included in this review were donated by Harvest Technologies.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Gregory Lutz is the Chief Medical Advisor for Biorestorative Therapies, LLC. The authors have no other financial interests to disclose.
Rights and permissions
About this article
Cite this article
Monfett, M., Harrison, J., Boachie-Adjei, K. et al. Intradiscal platelet-rich plasma (PRP) injections for discogenic low back pain: an update. International Orthopaedics (SICOT) 40, 1321–1328 (2016). https://doi.org/10.1007/s00264-016-3178-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-016-3178-3